Publications

  1. Flanagan KC, Earls J, Hiken J, Wellinghoff RL, Ponder MM, McLeod HL, Westra WH, Vavinskaya V, Sutton L, Deichaite I, Macdonald OK, Welaya K, Wade J 3rd, Azzi G, Pippas AW, Slim J, Bank B, Sui X, Kossman SE, Shenkenberg TD, Alexander WL, Price KA, Ley J, Messina DN, Glasscock JI, Colevas AD, Cohen EEW, Adkins D, Duncavage EJ. Multicenter validation of an RNA-based assay to predict anti-PD-1 disease control in patients with recurrent or metastatic head and neck squamous cell carcinoma: the PREDAPT study. J Immunother Cancer. 2024 Nov 3; 12 (11) Epub 2024 Nov 03
    View PubMed
  2. Suleiman R, McGarrah P, Baral B, Owen D, Vera Aguilera J, Halfdanarson TR, Price KA, Fuentes Bayne HE. Alpelisib and Immunotherapy: A Promising Combination for Recurrent and Metastatic Squamous Cell Carcinoma of the Head and Neck. Cancer Rep (Hoboken). 2024 Oct; 7 (10):e70023
    View PubMed
  3. Armstrong MF, Burkett BJ, O'Byrne TJ, Gottlich HC, Yin LX, Tasche KK, Price DL, Moore EJ, Routman DM, Gamez M, Lester SC, Neben-Wittich MA, Ma DJ, Price KA, Lowe VJ, Van Abel KM. Cancer in Patients With Incidental Asymmetric Oropharynx Positron Emission Tomography Uptake. JAMA Otolaryngol Head Neck Surg. 2024 Aug 29 [Epub ahead of print]
    View PubMed
  4. Baral B, Suleiman R, Fazer-Posorske CA, Ma DJ, McGarrah PW, Thome SD, Molina JR, Price KA, Halfdanarson TR, Fuentes HE. Advancing head and neck cancer management: Unveiling the diagnostic and therapeutic potentials of molecular profiling. Head Neck. 2024 Jul 20 Epub 2024 July 20
    View PubMed
  5. Rosenberg AJ, Perez CA, Guo W, de Oliveira Novaes JM, da Silva Reis KFO, McGarrah PW, Price KAR. Breaking Ground in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Novel Therapies Beyond PD-L1 Immunotherapy. Am Soc Clin Oncol Educ Book. 2024 Jun; 44 (3):e433330
    View PubMed
  6. Fazer-Posorske, Guenzel, McGrath, Ziebarth, Kunkel, Chintakuntlawar, Price MD. Overview of head and neck cancer and the role of survivorship care Journal of Dermatology for Physician Assistants. 2024; 18(1):3-9.
  7. Aden AA, Olawuni FO, Abdel-Halim CN, Zhu AQ, Haller TJ, O'Byrne TJ, Moore EJ, Price DL, Tasche KL, Ma DJ, Lester SC, Gamez M, Neben-Wittich MA, Price K, Fuentes-Bayne HE, Routman D, Van Abel KM. Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancer. Oral Oncol. 2024 Feb; 149:106675. Epub 2024 Jan 11.
    View PubMed
  8. Hong S, Garces YI, Price KA, Shinya Y, Parney IF, Link MJ, Pollock BE. Treatment outcomes of single-fraction stereotactic radiosurgery for adenoid cystic carcinoma: a case series of 55 patients. J Neurooncol. 2024 Jan; 166 (2):369-376 Epub 2024 Jan 05
    View PubMed
  9. Price KAR, Warsame R, O'Shea M, Kim Y, Ellingson SA, Asiedu GB. A Mixed-Method Approach to Explore Successful Recruitment and Treatment of Minority Patients on Therapeutic Cancer Clinical Trials at a Tertiary Referral Center Using Photo-Elicitation Interviews. Health Equity. 2024; 8 (1):117-127 Epub 2024 Feb 28
    View PubMed
  10. Cooper AC, Fazer CA, Chintakuntlawar AV, Fuentes Bayne HE, McGarrah PW, Price KAR. Capecitabine for Salvage Treatment of Patients With Heavily Pretreated Human Papillomavirus-Associated Oropharynx Cancer With Distant Metastases. J Adv Pract Oncol. 2023 Nov; 14(7):571-575.
    View PubMed
  11. Abdel-Halim CN, O'Byrne TJ, Graves JP, Akpala CO, Moore EJ, Price DL, Tasche KT, Ma DJ, Neben-Wittich MA, Lester SC, Gamez M, Price KA, Bayne HEF, Rwigema JCM, Patel SH, McGee LA, Janus JR, Nagel TH, Hinni ML, Savvides PS, Van Abel KM, Routman DM. Patterns and distribution of regional nodal involvement and recurrence in a surgically treated oropharyngeal squamous cell carcinoma cohort at a tertiary center. Oral Oncol. 2023 Nov; 146:106569 Epub 2023 Sept 19
    View PubMed
  12. Laughlin BS, Ebrahimi S, Voss MM, Patel SH, Foote RL, McGee LA, Garcia J, Ma DJ, Garces YI, Wittich MAN, Price KA, Schmitt A, Zhai Q, May BC, Nagel TH, Hinni ML, Chintakuntlawar AV, DeWees TA, Rwigema JM. Clinicopathologic Factors and Their Association with Outcomes of Salivary Duct Carcinoma: A Multicenter Experience. Adv Radiat Oncol. 2023 Jul-Aug; 8 (4):101204 Epub 2023 Mar 01
    View PubMed
  13. Karp EE, Yin LX, O'Byrne TJ, Lu LY, Routman DM, Lester SC, Neben Wittich MA, Ma DJ, Price KA, Chintakuntlawar AV, Tasche KK, Price DL, Moore EJ, Van Abel KM. Diagnostic Delay in Human Papillomavirus Negative Oropharyngeal Squamous Cell Carcinoma. Laryngoscope. 2023 Jun; 133 (6):1394-1401 Epub 2022 July 19
    View PubMed
  14. Ehlers SL, Gudenkauf LM, Kacel EL, Hanna SM, Sinicrope PS, Patten CA, Morrison EL, Snuggerud J, Bevis D, Kirsch JL, Staab JP, Price KAR, Wahner-Hendrickson AE, Ruddy KJ. Real-World Implementation of Best-Evidence Cancer Distress Management: Truly Comprehensive Cancer Care. J Natl Compr Canc Netw. 2023 Jun; 21 (6):627-635
    View PubMed
  15. Gao RW, Routman DM, Harmsen WS, Ebrahimi S, Foote RL, Ma DJ, Neben-Wittich M, McGee LA, Patel SH, Moore EJ, Choby GW, Tasche KK, Price KA, Gamez ME, Lester SC. Adenoid cystic carcinoma of the head and neck: Patterns of recurrence and implications for intensity-modulated radiotherapy. Head Neck. 2023 Jan; 45 (1):187-196 Epub 2022 Oct 12
    View PubMed
  16. Ho AL, Foster NR, Zoroufy AJ, Campbell JD, Worden F, Price K, Adkins D, Bowles DW, Kang H, Burtness B, Sherman E, Morton R, Morris LGT, Nadeem Z, Katabi N, Munster P, Schwartz GK. Phase II Study of Enzalutamide for Patients With Androgen Receptor-Positive Salivary Gland Cancers (Alliance A091404). J Clin Oncol. 2022 Dec 20; 40 (36):4240-4249 Epub 2022 July 22
    View PubMed
  17. Yin LX, Routman DM, Day CN, Harmsen WS, Haller T, Bartemes K, Price DL, Moore EJ, Foote RL, Neben-Wittich M, Chintakuntlawar AV, Ma DJ, Price KA, Van Abel KM. Low postoperative lymphocyte count increases risk of progression in human papillomavirus associated oropharyngeal cancer. Head Neck. 2022 Dec; 44(12):2760-2768. Epub 2022 Sep 21.
    View PubMed
  18. Warsame R, Cook J, Fruth B, Hubbard J, Croghan K, Price KAR, Jatoi A, Kumar S, Thompson C, Buckner J, Dispenzieri A, Sloan J, Dueck AC. A prospective, randomized trial of patient-reported outcome measures to drive management decisions in hematology and oncology. Contemp Clin Trials Commun. 2022 Oct; 29:100964 Epub 2022 July 13
    View PubMed
  19. Price K, Van Abel KM, Moore EJ, Patel SH, Hinni ML, Chintakuntlawar AV, Graner D, Neben-Wittich M, Garces YI, Price DL, Janus JR, Foster NR, Ginos BF, Foote RL, Ma D. Long-Term Toxic Effects, Swallow Function, and Quality of Life on MC1273: A Phase 2 Study of Dose De-escalation for Adjuvant Chemoradiation in Human Papillomavirus-Positive Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys. 2022 Oct 1; 114 (2):256-265 Epub 2022 June 05
    View PubMed
  20. Salinas M, Chintakuntlawar A, Arasomwan I, Eltahir A, Price KAR. Emerging Disparities in Prevention and Survival Outcomes for Patients with Head and Neck Cancer and Recommendations for Health Equity. Curr Oncol Rep. 2022 Sep; 24 (9):1153-1161 Epub 2022 Apr 14
    View PubMed
  21. Even C, Delord JP, Price KA, Nakagawa K, Oh DY, Burge M, Chung HC, Doi T, Fakih M, Takahashi S, Yao L, Jin F, Norwood K, Hansen AR. Evaluation of pembrolizumab monotherapy in patients with previously treated advanced salivary gland carcinoma in the phase 2 KEYNOTE-158 study. Eur J Cancer. 2022 Aug; 171:259-268 Epub 2022 June 28
    View PubMed
  22. Routman DM, Kumar S, Chera BS, Jethwa KR, Van Abel KM, Frechette K, DeWees T, Golafshar M, Garcia JJ, Price DL, Kasperbauer JL, Patel SH, Neben-Wittich MA, Laack NL, Chintakuntlawar AV, Price KA, Liu MC, Foote RL, Moore EJ, Gupta GP, Ma DJ. Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma. Int J Radiat Oncol Biol Phys. 2022 Jul 1; 113 (3):530-538 Epub 2022 Feb 12
    View PubMed
  23. Karp EE, Garcia JJ, Chan SA, Van Abel KM, Moore EJ, Janus JR, Kasperbauer JL, Olsen KD, Hinni ML, Price KA, Ma DJ, Foote RL, Neben Wittich MA, Price DL. The role of total parotidectomy in high-grade parotid malignancy: A multisurgeon retrospective review. Am J Otolaryngol. 2022 Jan-Feb; 43(1):103194. Epub 2021 Sep 02.
    View PubMed
  24. Price K, Van Abel KM, Moore EJ, Patel SH, Hinni ML, Chintakuntlawar AV, Graner D, Neben-Wittich M, Garces YI, Price DL, Janus JR, Foster NR, Ginos BF, Foote RL, Ma D. Long-term toxic effects, swallow function, and quality of life on MC1273: a phase 2 study of dose de-escalation for adjuvant chemoradiation in human papillomavirus-positive oropharyngeal cancer. International Journal of Radiation Oncology, Biology, Physics. 2022; 114 (2):256-65
  25. Yin LX, Karp EE, Elias A, O'Byrne TJ, Routman DM, Price DL, Kasperbauer JL, Neben-Wittich M, Chintakuntlawar AV, Price KA, Ma DJ, Foote RL, Moore EJ, Van Abel KM. Disease Profile and Oncologic Outcomes After Delayed Diagnosis of Human Papillomavirus-Associated Oropharyngeal Cancer. Otolaryngol Head Neck Surg. 2021 Dec; 165(6):830-837. Epub 2021 Mar 23.
    View PubMed
  26. Warsame RM, Asiedu GB, Kumbamu A, Cook J, Hayes SN, Thompson CA, Hobday TJ, Price KAR. Assessment of Discrimination, Bias, and Inclusion in a United States Hematology and Oncology Fellowship Program. JAMA Netw Open. 2021 Nov 1; 4 (11):e2133199 Epub 2021 Nov 01
    View PubMed
  27. Hazim AZ, Reed CT, Price KA, Foote RL, Ma DJ, Neben-Wittich M, DeLone DR, Jenkins SM, Smith CY, Chintakuntlawar AV. Survival outcomes in locally advanced cutaneous squamous cell carcinoma presenting with clinical perineural invasion alone. Head Neck. 2021 Jul; 43 (7):1995-2001 Epub 2021 Feb 28
    View PubMed
  28. Riaz N, Sherman E, Pei X, Schoder H, Grkovski M, Paudyal R, Katabi N, Selenica P, Yamaguchi TN, Ma D, Lee SK, Shah R, Kumar R, Kuo F, Ratnakumar A, Aleynick N, Brown D, Zhang Z, Hatzoglou V, Liu LY, Salcedo A, Tsai CJ, McBride S, Morris LGT, Boyle J, Singh B, Higginson DS, Damerla RR, Paula ADC, Price K, Moore EJ, Garcia JJ, Foote R, Ho A, Wong RJ, Chan TA, Powell SN, Boutros PC, Humm JL, Shukla-Dave A, Pfister D, Reis-Filho JS, Lee N. Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial. J Natl Cancer Inst. 2021 Jun 1; 113 (6):742-751
    View PubMed
  29. Larish A, Yin L, Glaser G, Moore E, Bakkum-Gamez J, Routman D, Ma D, Price D, Janus J, Price K, Chintakuntlawar A, Neben-Wittich M, Foote R, Van Abel K. Human Papillomavirus-Associated Anogenital Pathology in Females With HPV-Positive Oropharyngeal Squamous Cell Carcinoma. Otolaryngol Head Neck Surg. 2021 Feb; 164 (2):369-374 Epub 2020 July 14
    View PubMed
  30. Moore EJ, Van Abel KM, Routman DM, Lohse CM, Price KAR, Neben-Wittich M, Chintakuntlawar AV, Price DL, Kasperbauer JL, Garcia JJ, Hinni ML, Patel SH, Janus JR, Foote RL, Ma DJ. Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy. Head Neck. 2021 Jan; 43 (1):229-237 Epub 2020 Sept 23
    View PubMed
  31. Chatzopoulos K, Collins AR, Sotiriou S, Keeney MG, Visscher DW, Rivera M, Schembri-Wismayer DJ, Lewis JE, Greipp PT, Sukov WR, Chintakuntlawar AV, Price KA, Garcia JJ. Increased ERBB2 Gene Copy Numbers Reveal a Subset of Salivary Duct Carcinomas with High Densities of Tumor Infiltrating Lymphocytes and PD-L1 Expression. Head Neck Pathol. 2020 Dec; 14 (4):951-965 Epub 2020 Apr 29
    View PubMed
  32. Van Abel KM, Routman DM, Moore EJ, Ma DJ, Yin LX, Fields PA, Schofield M, Bartemes KR, Chatzopoulos K, Price DL, Janus JR, Kasperbauer JL, Price KA, Chintakuntlawar AV, Neben-Wittich MA, Foote RL, Garcia JJ. T cell fraction impacts oncologic outcomes in human papillomavirus associated oropharyngeal squamous cell carcinoma. Oral Oncol. 2020 Dec; 111:104894 Epub 2020 July 23
    View PubMed
  33. Andrews JR, Ahmed ME, Motterle G, Albadri ST, Haloi R, Karnes RJ, Kwon ED, Price KA. A Rare Case of Prostate-Specific Antigen-Producing Metastatic Parotid Adenocarcinoma Developing Androgen Receptor Resistance. Mayo Clin Proc Innov Qual Outcomes. 2020 Oct; 4(5):601-607. Epub 2020 Aug 19.
    View PubMed
  34. Yin LX, Puccinelli CL, Price DL, Karp EE, Price KA, Ma DJ, Lohse C, Moore EJ, Abel KMV. The prognostic role of medical comorbidities in surgically treated human papillomavirus-associated oropharyngeal squamous cell carcinoma. Oral Oncol. 2020 Sep; 108:104822 Epub 2020 June 03
    View PubMed
  35. Price KAR, Nichols AC, Shen CJ, Rammal A, Lang P, Palma DA, Rosenberg AJ, Chera BS, Agrawal N. Novel Strategies to Effectively De-escalate Curative-Intent Therapy for Patients With HPV-Associated Oropharyngeal Cancer: Current and Future Directions. Am Soc Clin Oncol Educ Book. 2020 Mar; 40:1-13
    View PubMed
  36. Fazer C, Price KA. Management of Immune-Related Dermatitis and Mucositis Associated With Pembrolizumab in Metastatic Human Papillomavirus-Associated Squamous Cell Carcinoma of the Oropharynx. JCO Oncol Pract. 2020 Feb; 16 (2_suppl):20s-24s
    View PubMed
  37. Ma DJ, Price KA, Moore EJ, Patel SH, Hinni ML, Garcia JJ, Graner DE, Neben-Wittich M, Garces YI, Chintakuntlawar AV, Price DL, Van Abel KM, Kasperbauer JL, Janus JR, Waddle M, Miller RC, Shiraishi S, Mutter RW, Corbin KS, Park SS, Foote RL. Reply to A.S. Garden. J Clin Oncol 2019 Dec 20; 37 (36):3559-3560 Epub 2019 Sept 26
    View PubMed
  38. Chintakuntlawar AV, Yin J, Foote RL, Kasperbauer JL, Rivera M, Asmus E, Garces Y, Garces NI, Janus JR, Liu M, Ma DJ, Moore EJ, Morris JC 3rd, Neben-Wittich M, Price DL, Price KA, Ryder M, Van Abel KM, Hilger C, Samb E, Bible KC. A Phase 2 Study of Pembrolizumab Combined with Chemoradiotherapy as Initial Treatment for Anaplastic Thyroid Cancer. Thyroid. 2019 Nov; 29 (11):1615-1622
    View PubMed
  39. Van Abel KM, Quick MH, Graner DE, Lohse CM, Price DL, Price KAR, Ma DJ, Moore EJ. Outcomes following TORS for HPV-positive oropharyngeal carcinoma: PEGs, tracheostomies, and beyond. Am J Otolaryngol. 2019 Sep - Oct; 40 (5):729-734 Epub 2019 July 03
    View PubMed
  40. Ma DJ, Price KA, Moore EJ, Patel SH, Hinni ML, Garcia JJ, Graner DE, Foster NR, Ginos B, Neben-Wittich M, Garces YI, Chintakuntlawar AV, Price DL, Olsen KD, Van Abel KM, Kasperbauer JL, Janus JR, Waddle M, Miller R, Shiraishi S, Foote RL. Phase II Evaluation of Aggressive Dose De-Escalation for Adjuvant Chemoradiotherapy in Human Papillomavirus-Associated Oropharynx Squamous Cell Carcinoma. J Clin Oncol. 2019 Aug 1; 37 (22):1909-1918 Epub 2019 June 04
    View PubMed
  41. Wang Y, Zhou S, Yang F, Qi X, Wang X, Guan X, Shen C, Duma N, Vera Aguilera J, Chintakuntlawar A, Price KA, Molina JR, Pagliaro LC, Halfdanarson TR, Grothey A, Markovic SN, Nowakowski GS, Ansell SM, Wang ML. Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis. JAMA Oncol. 2019 Jul 1; 5 (7):1008-1019
    View PubMed
  42. Viscuse PV, Price K. Marked responses to pemetrexed chemotherapy for metastatic adenocarcinoma of the parotid gland: Case series. Head Neck. 2019 Jun; 41 (6):E99-E103 Epub 2019 Feb 01
    View PubMed
  43. Miller KC, Marinelli JP, Van Gompel JJ, Link MJ, Janus JR, Foote RL, Price KA, Garcia J, Rivera M, Chintakuntlawar AV. Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma. Head Neck. 2019 May; 41 (5):1335-1341 Epub 2018 Dec 10
    View PubMed
  44. Viscuse PV, Price KA, Garcia JJ, Schembri-Wismayer DJ, Chintakuntlawar AV. First Line Androgen Deprivation Therapy vs. Chemotherapy for Patients With Androgen Receptor Positive Recurrent or Metastatic Salivary Gland Carcinoma-A Retrospective Study. Front Oncol. 2019; 9:701 Epub 2019 Aug 02
    View PubMed
  45. Marinelli JP, Janus JR, Van Gompel JJ, Link MJ, Foote RL, Lohse CM, Price KA, Chintakuntlawar AV. Esthesioneuroblastoma with distant metastases: Systematic review & meta-analysis. Head Neck. 2018 Oct; 40 (10):2295-2303 Epub 2018 May 13
    View PubMed
  46. Pasalic D, Funk RK, Garcia JJ, Price DL, Price KA, Harmsen WS, Patel SH, Young GD, Foote RL, Moore EJ, Ma DJ. Magnitude of benefit for adjuvant radiotherapy following minimally invasive surgery in intermediate to high risk HPV-positive oropharyngeal squamous cell carcinoma. Oral Oncol. 2018 Jul; 82:181-186 Epub 2018 June 06
    View PubMed
  47. Ho TP, Jewison M, Ruddy KJ, Price K . Pilot Telephone Intervention to Improve Survivorship Care Clinics in Surgery. 2017; 2:1795.
  48. Routman DM, Funk RK, Tangsriwong K, Lin A, Keeney MG, Garcia JJ, Zarka MA, Lewis JT, Stoddard DG, Moore EJ, Day CN, Zhai Q, Price KA, Lukens JN, Swisher-McClure S, Weinstein GS, O'Malley BW Jr, Foote RL, Ma DJ. Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional Review. Int J Radiat Oncol Biol Phys. 2017 Nov 15; 99 (4):938-946 Epub 2017 June 28
    View PubMed
  49. Alsidawi S, Price KA, Chintakuntlawar AV, Westin GF, Garcia JJ, Ma DJ, Okuno SH. Characteristics and long-term outcomes of head and neck squamous cell carcinoma after solid organ transplantation. Oral Oncol. 2017 Sep; 72:104-109 Epub 2017 July 17
    View PubMed
  50. Viscuse PV, Price K, Millstine D, Bhagra A, Bauer B, Ruddy KJ. Integrative medicine in cancer survivors. Curr Opin Oncol. 2017 Jul; 29 (4):235-242
    View PubMed
  51. Sorenson KR, Piovezani Ramos G, Villasboas Bisneto JC, Price K. Targeted Approaches Applied to Uncommon Diseases: A Case of Salivary Duct Carcinoma Metastatic to the Brain Treated with the Multikinase Inhibitor Neratinib. Case Rep Oncol. 2017 May-Aug; 10 (2):726-731 Epub 2017 Aug 09
    View PubMed
  52. Chintakuntlawar AV, Shon W, Erickson-Johnson M, Bilodeau E, Jenkins SM, Davidson JA, Keeney MG, Rivera M, Price DL, Moore EJ, Olsen KD, Kasperbauer JL, Foote RL, Price KA, Garcia JJ. High-grade transformation of acinic cell carcinoma: an inadequately treated entity? Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 May; 121: (5)542-549.e1.
    View PubMed
  53. Funk RK, Moore EJ, Garcia JJ, Harmsen WS, Stoddard DG, Vencio EF, Foote RL, Price KA, Ma DJ. Risk factors for locoregional relapse after transoral robotic surgery for human papillomavirus-related oropharyngeal squamous cell carcinoma. Head Neck. 2016 Apr; 38 Suppl 1:E1674-9 Epub 2015 Dec 15
    View PubMed
  54. Brobst TD, Garcia JJ, Price KA, Gao G, Smith DI, Price DL. Concurrent Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx in a Married Couple. Case Rep Otolaryngol. 2016; 2016:8481235 Epub 2016 June 22
    View PubMed
  55. Chintakuntlawar AV, Okuno SH, Price KA. Systemic therapy for recurrent or metastatic salivary gland malignancies. Cancers Head Neck. 2016; 1:11 Epub 2016 Sept 01
    View PubMed
  56. Cutshall SM, Cha SS, Ness SM, Stan DL, Christensen SA, Bhagra A, Price KA, Thompson CA, Hashmi SK, Chon TY, McCray TJ, Sood A, Bauer BA, Ruddy KJ. Symptom burden and integrative medicine in cancer survivorship. Support Care Cancer. 2015 Oct; 23 (10):2989-94 Epub 2015 Feb 28
    View PubMed
  57. Price KA, Cohen EE. Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN). Oral Oncol. 2015 May; 51 (5):399-408 Epub 2015 Feb 26
    View PubMed
  58. Pachman DR, Price KA, Carey EC. Nonpharmacologic approach to fatigue in patients with cancer. Cancer J. 2014 Sep-Oct; 20(5):313-8.
    View PubMed
  59. Vaa B, Kohli M, Price KA, Swetz KM. Solitary cystic cerebellar metastasis in a patient with invasive transitional cell carcinoma of the bladder. BMJ Case Rep. 2014 Jun 11; 2014 Epub 2014 June 11
    View PubMed
  60. Geiger JL, Lazim AF, Walsh FJ, Foote RL, Moore EJ, Okuno SH, Olsen KD, Kasperbauer JL, Price DL, Garces YI, Ma DJ, Neben-Wittich MA, Molina JR, Garcia JJ, Price KA. Adjuvant chemoradiation therapy with high-dose versus weekly cisplatin for resected, locally-advanced HPV/p16-positive and negative head and neck squamous cell carcinoma. Oral Oncol. 2014 Apr; 50 (4):311-8 Epub 2014 Jan 24
    View PubMed
  61. Geiger JL, Garcia JJ, Price KA. Acinic cell carcinoma of the salivary gland with metastatic spread to the pancreas. Case Rep Oncol. 2014 Jan; 7 (1):195-8 Epub 2014 Mar 13
    View PubMed
  62. Lim MY, Stephens EK, Novotny P, Price K, Salayi M, Roeker L, Peethambaram P, Jatoi A. Self-perceptions of age among 292 chemotherapy-treated cancer patients: Exploring associations with symptoms and survival. J Geriatr Oncol. 2013 Jul; 4(3):249-54.
    View PubMed
  63. Chaft JE, Rusch V, Ginsberg MS, Paik PK, Finley DJ, Kris MG, Price KAR, Azzoli CG, Fury MG, Riely GJ, Krug LM, Downey RJ, Bains MS, Sima CS, Rizk N, Travis WD, Rizvi NA. Phase II trial of neoadjuvant bevacizumab plus chemotherapy and adjuvant bevacizumab in patients with resectable nonsquamous non-small cell lung cancers. J Thorac Surg. 2013; 8(8):1084-90.
  64. Price KA, Cohen EE. Current treatment options for metastatic head and neck cancer. Curr Treat Options Oncol. 2012 Mar; 13 (1):35-46
    View PubMed
  65. Eadens MJ, Robinson SI, Price KA. Effectiveness of maintenance treatments for nonsmall cell lung cancer. Lung Cancer (Auckl). 2011; 2:29-39 Epub 2011 July 21
    View PubMed
  66. Price KA. Hydration in cancer patients. Curr Opin Support Palliat Care. 2010 Dec; 4(4):276-80.
    View PubMed
  67. Price KA, Azzoli CG, Krug LM, Pietanza MC, Rizvi NA, Pao W, Kris MG, Riely GJ, Heelan RT, Arcila ME, Miller VA. Phase II trial of gefitinib and everolimus in advanced non-small cell lung cancer. J Thorac Oncol. 2010 Oct; 5(10):1623-9.
    View PubMed
  68. Price KA, Azzoli CG, Gaspar LE. Chemoradiation for unresectable stage III non-small cell lung cancer. Semin Thorac Cardiovasc Surg. 2008 Fall; 20(3):204-9.
    View PubMed
  69. Price KA, Miller V. Treatment of a patient with non-small cell lung cancer who as never smoked. Oncology Consultations. 2008; 5(2).
  70. Rowe KA, Makhubele B, Hargreaves JR, Porter JD, Hausler HP, Pronyk PM. Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings? Int J Tuberc Lung Dis. 2005 Mar; 9 (3):263-9
    View PubMed
  71. Rowe KA, Makhubele B, Hargreaves J, Porter J, Hausler H, Pronyk P. Adherence to tuberculosis preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings? Int J Tub Lung Dis. 2005; 9(3):263-9.
  72. Pulerwitz TC, Waxman S, Rowe KA, Quist WC, Lipinska I, Verrier RL. Transatrial access to the normal pericardial space for local cardiac therapy: preclinical safety testing with aspirin and pulmonary artery hypertension. J Interv Cardiol. 2001 Oct; 14(5):493-8.
    View PubMed
  73. Moreno R, Waxman S, Rowe K, Verrier RL. Intrapericardial beta-adrenergic blockade with esmolol exerts a potent antitachycardic effect without depressing contractility. J Cardiovasc Pharmacol. 2000 Dec; 36(6):722-7.
    View PubMed
  74. Waxman S, Pulerwitz TC, Rowe KA, Quist WC, Verrier RL. Preclinical safety testing of percutaneous transatrial access to the normal pericardial space for local cardiac drug delivery and diagnostic sampling. Catheter Cardiovasc Interv. 2000 Apr; 49(4):472-7.
    View PubMed
  75. Rowe K, Moreno R, Lau TR, Wallooppillai U, Nearing BD, Kocsis B, Quattrochi J, Hobson JA, Verrier RL. Heart rate surges during REM sleep are associated with theta rhythm and PGO activity in cats. Am J Physiol. 1999 Sep; 277(3 Pt 2):R843-9.
    View PubMed
  76. Waxman S, Moreno R, Rowe KA, Verrier RL. Persistent primary coronary dilation induced by transatrial delivery of nitroglycerin into the pericardial space: a novel approach for local cardiac drug delivery. J Am Coll Cardiol. 1999 Jun; 33(7):2073-7.
    View PubMed